Latest Breaking News On - பல்கலைக்கழகம் ஆஃப் கோபெந்ஹேகந் துறை - Page 1 : comparemela.com

New Method May Help Develop Treatments for Range of Metabolic Disorders Eli Lilly will apply Dicerna Pharmaceuticals’ GalXC™ RNA interference (RNAi) technology platform to discover, develop, and commercialize new treatments based on more than 10 targets in cardio-metabolic disease, neurodegeneration, and pain, through a collaboration that could generate more than $3.7 billion for Dicerna. [© lily/Fotolia] April 29, 2021 Unlocking the underlying mechanics of cellular metabolism and hormonal regulation would go a long way toward improving human health, and a team of investigators at the University of Copenhagen and the University Hospital of Bern may have just found new methods to control a group of enzymes that affect our metabolism. The new findings published recently in

Simon bo jensenNature communicationsUniversity of copenhagenUniversity hospital of bernUniversity of copenhagen departmentUniversity hospitalNikos hatzakisசிமோன் போ ஜென்சன்இயற்கை தகவல்தொடர்புகள்பல்கலைக்கழகம் ஆஃப் கோபெந்ஹேகந்பல்கலைக்கழகம் மருத்துவமனை ஆஃப் பெர்ன்பல்கலைக்கழகம் ஆஃப் கோபெந்ஹேகந் துறைபல்கலைக்கழகம் மருத்துவமனை